GenomicTestingCalcificationsLymphNodeStatusPrecisionMedicineSelf-examinationEndometrialCancerAntiemeticAdjuvantTherapyLiquidBiopsyAxillarySamplingPathologicResponseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.HormoneReceptorStatusmTORInhibitorsMastitisNodeNegativeFibroadenomaChemopreventionRelapsePagetDiseaseMastodyniaOligometastasesCAMBOCANeoadjuvantTherapyCytotoxicTripleNegativeBreastCancerFISHLumpER-BreastTomosynthesisHER-2AbsoluteRiskBenignPhyllodesTumorCo-survivorBrachytherapyImmunotherapyAlopeciaPalbociclibTumorGradeApoptosisDisease-FreeSurvivalRateRaloxifeneMethotrexateSERMKappaEpsilonAyurvedaPhyllodesTumorEstradiolBreastCancerPARPInhibitorsCystAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyPI3KinaseInhibitorsGailModelSclerosingAdenosisDoxorubicinMastalgiaCheckpointInhibitorGuaranteedRenewableInsuranceGermlineMutationEvidencesuggests thatphysical activitymay reduce therisk of breastcancersCachexiaECOGScore5-FluorouracilCytostaticBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MolecularBreastImagingBevacizumabDown-StagingBRCAGeneMultifocalTumorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEGFR(epidermalgrowth factorreceptor)NodePositiveTamoxifenCDK4/6InhibitorsRADMetastaticBreastCancerKi-67RateDocetaxelChemotherapyAromataseInhibitorsGeneMutationMetastasisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltFamilyHistoryTriplePositiveBreastCancerPaclitaxelInvasiveBreastCancerHormoneReplacementTherapyDefinitiveSurgeryAngiogenesisAdenocarcinomaBiopsyHerceptinLymphoscintigraphyER+FlowCytometryOvarianSuppressionAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenExcisionalBiopsyMorpheaIn-situCarcinoma1 in 8womenACChemotherapyMRIRadiotherapyEstrogenLumpectomyDoseDenseTherapyBilateralProphylacticMastectomyTyrosine-KinaseInhibitorFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AntibodyTherapyMegestrolAcetateIntraductalPapillomaGeneticCounselingLCISNeoplasmCyclophosphamideOophorectomyProgestinLapatinibDiabeticMastopathyAnastrozoleGeneticPredispositionlatissimusflapMultimodalityTherapyStagingAdvocacyPalpationCMFChemotherapyBI-RADSMastectomyDimplingCapecitabineGenomicTestingCalcificationsLymphNodeStatusPrecisionMedicineSelf-examinationEndometrialCancerAntiemeticAdjuvantTherapyLiquidBiopsyAxillarySamplingPathologicResponseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.HormoneReceptorStatusmTORInhibitorsMastitisNodeNegativeFibroadenomaChemopreventionRelapsePagetDiseaseMastodyniaOligometastasesCAMBOCANeoadjuvantTherapyCytotoxicTripleNegativeBreastCancerFISHLumpER-BreastTomosynthesisHER-2AbsoluteRiskBenignPhyllodesTumorCo-survivorBrachytherapyImmunotherapyAlopeciaPalbociclibTumorGradeApoptosisDisease-FreeSurvivalRateRaloxifeneMethotrexateSERMKappaEpsilonAyurvedaPhyllodesTumorEstradiolBreastCancerPARPInhibitorsCystAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyPI3KinaseInhibitorsGailModelSclerosingAdenosisDoxorubicinMastalgiaCheckpointInhibitorGuaranteedRenewableInsuranceGermlineMutationEvidencesuggests thatphysical activitymay reduce therisk of breastcancersCachexiaECOGScore5-FluorouracilCytostaticBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MolecularBreastImagingBevacizumabDown-StagingBRCAGeneMultifocalTumorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEGFR(epidermalgrowth factorreceptor)NodePositiveTamoxifenCDK4/6InhibitorsRADMetastaticBreastCancerKi-67RateDocetaxelChemotherapyAromataseInhibitorsGeneMutationMetastasisMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltFamilyHistoryTriplePositiveBreastCancerPaclitaxelInvasiveBreastCancerHormoneReplacementTherapyDefinitiveSurgeryAngiogenesisAdenocarcinomaBiopsyHerceptinLymphoscintigraphyER+FlowCytometryOvarianSuppressionAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenExcisionalBiopsyMorpheaIn-situCarcinoma1 in 8womenACChemotherapyMRIRadiotherapyEstrogenLumpectomyDoseDenseTherapyBilateralProphylacticMastectomyTyrosine-KinaseInhibitorFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AntibodyTherapyMegestrolAcetateIntraductalPapillomaGeneticCounselingLCISNeoplasmCyclophosphamideOophorectomyProgestinLapatinibDiabeticMastopathyAnastrozoleGeneticPredispositionlatissimusflapMultimodalityTherapyStagingAdvocacyPalpationCMFChemotherapyBI-RADSMastectomyDimplingCapecitabine

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Genomic Testing
  2. Calcifications
  3. Lymph Node Status
  4. Precision Medicine
  5. Self-examination
  6. Endometrial Cancer
  7. Antiemetic
  8. Adjuvant Therapy
  9. Liquid Biopsy
  10. Axillary Sampling
  11. Pathologic Response
  12. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  13. Hormone Receptor Status
  14. mTOR Inhibitors
  15. Mastitis
  16. Node Negative
  17. Fibroadenoma
  18. Chemoprevention
  19. Relapse
  20. Paget Disease
  21. Mastodynia
  22. Oligometastases
  23. CAM
  24. BOCA
  25. Neoadjuvant Therapy
  26. Cytotoxic
  27. Triple Negative Breast Cancer
  28. FISH
  29. Lump
  30. ER-
  31. Breast Tomosynthesis
  32. HER-2
  33. Absolute Risk
  34. Benign Phyllodes Tumor
  35. Co-survivor
  36. Brachytherapy
  37. Immunotherapy
  38. Alopecia
  39. Palbociclib
  40. Tumor Grade
  41. Apoptosis
  42. Disease-Free Survival Rate
  43. Raloxifene
  44. Methotrexate
  45. SERM
  46. Kappa Epsilon
  47. Ayurveda
  48. Phyllodes Tumor
  49. Estradiol
  50. Breast Cancer
  51. PARP Inhibitors
  52. Cyst
  53. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  54. Women ages 40+ should have a clinical breast exam at least yearly
  55. PI3 Kinase Inhibitors
  56. Gail Model
  57. Sclerosing Adenosis
  58. Doxorubicin
  59. Mastalgia
  60. Checkpoint Inhibitor
  61. Guaranteed Renewable Insurance
  62. Germline Mutation
  63. Evidence suggests that physical activity may reduce the risk of breast cancers
  64. Cachexia
  65. ECOG Score
  66. 5-Fluorouracil
  67. Cytostatic
  68. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  69. Molecular Breast Imaging
  70. Bevacizumab
  71. Down-Staging
  72. BRCA Gene
  73. Multifocal Tumors
  74. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  75. EGFR (epidermal growth factor receptor)
  76. Node Positive
  77. Tamoxifen
  78. CDK4/6 Inhibitors
  79. RAD
  80. Metastatic Breast Cancer
  81. Ki-67 Rate
  82. Docetaxel
  83. Chemotherapy
  84. Aromatase Inhibitors
  85. Gene Mutation
  86. Metastasis
  87. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  88. Family History
  89. Triple Positive Breast Cancer
  90. Paclitaxel
  91. Invasive Breast Cancer
  92. Hormone Replacement Therapy
  93. Definitive Surgery
  94. Angiogenesis
  95. Adenocarcinoma
  96. Biopsy
  97. Herceptin
  98. Lymphoscintigraphy
  99. ER+
  100. Flow Cytometry
  101. Ovarian Suppression
  102. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  103. Excisional Biopsy
  104. Morphea
  105. In-situ Carcinoma
  106. 1 in 8 women
  107. AC Chemotherapy
  108. MRI
  109. Radiotherapy
  110. Estrogen
  111. Lumpectomy
  112. Dose Dense Therapy
  113. Bilateral Prophylactic Mastectomy
  114. Tyrosine-Kinase Inhibitor
  115. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  116. Antibody Therapy
  117. Megestrol Acetate
  118. Intraductal Papilloma
  119. Genetic Counseling
  120. LCIS
  121. Neoplasm
  122. Cyclophosphamide
  123. Oophorectomy
  124. Progestin
  125. Lapatinib
  126. Diabetic Mastopathy
  127. Anastrozole
  128. Genetic Predisposition
  129. latissimus flap
  130. Multimodality Therapy
  131. Staging
  132. Advocacy
  133. Palpation
  134. CMF Chemotherapy
  135. BI-RADS
  136. Mastectomy
  137. Dimpling
  138. Capecitabine